PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.\', \'Guangzhou Eighth People\'s Hospital, Guangzhou Medical University, Guangzhou, China.\', \'State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.\', \'Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.\', \'Medical Department, Hankou Hospital of Wuhan City, Wuhan, China.\', \'Department of Haematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamainternmed.2020.5503
?:doi
?:hasPublicationType
?:journal
  • JAMA internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 32910179
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.032
?:rankingScore_hIndex
  • 300
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all